Patents by Inventor Shizue Nakagawa

Shizue Nakagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060189669
    Abstract: To provide a pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy or preproliferative retinopathy, comprising a compound having angiotensin II antagonistic activity, or a salt thereof.
    Type: Application
    Filed: April 19, 2006
    Publication date: August 24, 2006
    Inventors: Shizue Nakagawa, Yasutaka Nagisa, Hitoshi Ikeda
  • Patent number: 7064141
    Abstract: To provide a pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy or preproliferative retinopathy, comprising a compound having angiotensin II antagonistic activity, or a salt thereof.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: June 20, 2006
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Shizue Nakagawa, Yasutaka Nagisa, Hitoshi Ikeda
  • Patent number: 6025467
    Abstract: Disclosed is a parathyroid hormone (PTH) (1-34) derivative in which at least the amino acid residue at the 10-position is substituted by an acidic amino acid residue. The derivatives of the present invention showing potent cAMP-producing activity and bone formation activity, and thus are useful as therapeutic agents for bone diseases, etc.
    Type: Grant
    Filed: March 19, 1998
    Date of Patent: February 15, 2000
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsunehiko Fukuda, Shizue Nakagawa, Junko Habashita, Shigehisa Taketomi
  • Patent number: 5434246
    Abstract: Parathyroid hormone (PTH) derivatives represented by the general formula: ##STR1## or a salt thereof, wherein R.sub.1 represents Ser or a D-.alpha.-amino acid residue of 4 or less carbon atoms;R.sub.2 represents a tetrapeptide chain which contains at least one water-soluble .alpha.-amino acid residue;R.sub.3 represents a tripeptide chain which contains at least one water-soluble .alpha.-amino acid residue; andR.sub.4 represents an aromatic amino acid residue or an amide thereof,except that R.sub.1 is Ser when R.sub.2 is His-Leu-Asn-Ser, R.sub.3 is E-F-Gwherein E is Arg or His, F is Lys or His, G is Lys, Leu or Gln, are disclosed.The parathyroid hormone derivatives of the present invention are stable and have high biological activity, therefore they are useful as drugs for bone diseases and the like.
    Type: Grant
    Filed: March 16, 1993
    Date of Patent: July 18, 1995
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Tsunehiko Fukuda, Shizue Nakagawa, Shigehisa Taketomi
  • Patent number: 5393869
    Abstract: Disclosed are peptides and salts thereof represented by general formul ##STR1## wherein R.sub.1 represents Ser or Aib; R.sub.2 represents Met or a naturally occurring hydrophobic amino acid; R.sub.3 represents Leu, Ser, Lys or an aromatic amino acid; R.sub.4 represents Gly or a D-.alpha.-amino acid; R.sub.5 represents Lys or Leu; R.sub.6 represents Met or a naturally occurring hydrophobic amino acid; R.sub.7 represents Glu or a basic amino acid; R.sub.8 represents Val or basic amino acid; R.sub.9 represents Trp or 2-(1,3-dithiolane-2-yl)Trp; R.sub.10 represents Arg or His; R.sub.11 represents Lys or His; R.sub.12 represents Lys, Gln or Leu; and R.sub.13 represents Phe or Phe-NH.sub.2 ; except that simultaneously R.sub.1 consists of Ser, R.sub.2 consists of Met, R.sub.3 consists of Leu, R.sub.4 consists of Gly, D-Ala or D-Pro, R.sub.5 consists of Lys, R.sub.6 consists of Met, R.sub.7 consists of Glu, R.sub.8 consists of Val, R.sub.9 consists of Trp, R.sub.10 consists of Arg, R.sub.11 consists of Lys and R.sub.
    Type: Grant
    Filed: September 25, 1991
    Date of Patent: February 28, 1995
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shizue Nakagawa, Tsunehiko Fukuda, Masahiro Kawase, Iwao Yamazaki